Exosomes Market Emerging Technological Trends, Future Growth and Business Opportunities

DNA Polymerase Market
DNA Polymerase Market

According to the most recent analysis by Emergen Research, the size of the global exosomes market reached USD 0.50 billion in 2021 and is predicted to experience a revenue CAGR of 18% over the projected period. Some of the major factors influencing the market revenue growth are the rising incidence of cancer, rapid scientific advancements in exosome research and technology development, improved exosome separation, characterization, and component detection methods, and rising numbers of clinical studies and trials in the area of exosome-based research.

As knowledge of exosome roles in disease pathophysiological pathways has grown, exosomes have been gradually produced for disease therapy and diagnosis.

Exosome-based nano-theranostics platforms and designer exosomes are two examples of recent scientific developments in exosome research and development that have facilitated highly promising diagnostic and therapeutic applications, sparking significant efforts for their translation into the clinical field. Future potential in exosome-related physiology, biochemistry, pathology, and therapeutics have been made possible by advances in exosome nanotechnology, giving researchers a strong foundation on which to design and develop exosome-based nano-theranostics systems.

Some Key Highlights From the Report

  • In 2021, Europe’s market contributed a modest portion of global sales. This is ascribed to elements including a rise in R&D activities and government-funded research initiatives in the area of exosome-based research.
  • The market growth in the region is also greatly aided by the expanding presence of notable industry players and others. For instance, Evox Therapeutics Ltd. (referred to as “Evox” or the “Firm”) raised USD 95.4 million in a Series C funding transaction, which was heavily oversubscribed due to the strong demand from both existing and new investors. OrbiMed and Invus also participated in the Series C round, which was led by Redmile Group.
  • In order to provide a standardised measurement of nanovesicle technology, Kimera Labs, one of the leading producers of placental MSC (pMSC) created exosomes in the U.S., established a novel and more useful method to quantify and describe exosomes on March 11, 2021, known as the Ross Unit (Ru).
  • Some major companies in the global market report include QIAGEN, Takara Bio Company, Illumina, Inc., Thermo Fisher Scientific, Inc., Codiak Biosciences, Exosome Diagnostics, Evox Therapeutics, ExCoBio Inc., Bio-Rad Laboratories Ltd., and Beckman Coulter, Inc.

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/exosomes-market

Emergen Research has segmented global exosomes market on the basis of type, product type, application, and region:

  • Type Outlook (Revenue, USD Billion; 2019-2030)
    • Biomarkers
    • Drug Delivery Systems
    • Vaccine Development
    • Therapeutic Agents
    • Others
  • Product Type Outlook (Revenue, USD Billion; 2019-2030)
    • Kits
    • Reagents
    • Instruments
  • Application Outlook (Revenue, USD Billion; 2019-2030)
    • Cancer
    • Neurodegenerative Disease
    • Cardiovascular Diseases
    • Infectious Diseases
    • Tissue Regeneration
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019-2030)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Latest Reports: c5isr systems market | peritoneal dialysis market

Trending Titles: ai in banking market | 5g fixed wireless access market

You may also like...

Leave a Reply

Your email address will not be published.